Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter J. Compton"'
Autor:
Alison N. Bonner, Andrew J. Spracklen, Rodrigo Fernandez-Gonzalez, Alexandru Florea, Mark Peifer, Emma M. Thornton-Kolbe, Peter J. Compton
Publikováno v:
Molecular Biology of the Cell. 30:2399-2421
Small Src homology domain 2 (SH2) and 3 (SH3) adapter proteins regulate cell fate and behavior by mediating interactions between cell surface receptors and downstream signaling effectors in many signal transduction pathways. The CT10 regulator of kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43ca654897197de6abf8e59a3087c610
https://doi.org/10.1091/mbc.e19-05-0302
https://doi.org/10.1091/mbc.e19-05-0302
Autor:
Peter J Compton-Craig, Dongni Feng, Hongyan Lu, Dmitry O. Traktuev, Stephanie Merfeld-Clauss, Keith L. March, Ivan P. Lupov
Publikováno v:
Circulation research. 115(9)
Rationale: Adipose stromal cells (ASC) are therapeutically potent progenitor cells that possess properties of pericytes. In vivo, ASC in combination with endothelial cells (EC) establish functional multilayer vessels, in which ASC form the outer vess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe0258510f48f400e68680434b43225
https://pubmed.ncbi.nlm.nih.gov/25301822
https://pubmed.ncbi.nlm.nih.gov/25301822
Autor:
Jane E. Huang, Margaret M. Kolb, Mark A. Socinski, Peter J. Compton, Corey J. Langer, Wallace Akerley, Lisa Wang
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(31)
Purpose Patients with non–small-cell lung cancer (NSCLC) and brain metastases have previously been excluded from trials of bevacizumab because of suspected risk of CNS hemorrhage. This phase II trial, AVF3752g (PASSPORT), specifically addressed bev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d66a330217fe34fae679161b2e52b7
https://pubmed.ncbi.nlm.nih.gov/19738122
https://pubmed.ncbi.nlm.nih.gov/19738122